Mesoblast treatment gets US panel's key tick of approval
The drug that Mesoblast has been trialling on some COVID-19 patients has just got the nod from a US regulator panel for treating children with severe responses to bone marrow transplants.
from Sydney Morning Herald - Latest News Read More
No comments:
Post a Comment
Thank You for sharing your views. I hope you like the arts posted.
No comments:
Post a Comment
Thank You for sharing your views. I hope you like the arts posted.